Evidence map›Paper›PMID 23918150›Full record

ArticleDigestive diseases and sciences2013

Apamin attenuated cerulein-induced acute pancreatitis by inhibition of JNK pathway in mice.

Gi-Sang Bae, Kwang-Ho Heo, Kyoung-Chel Park, Sun Bok Choi, Il-Joo Jo, Seung-Hee Seo, Dong-Goo Kim, Joon-Yeon Shin, Dae-Gil Kang, Ho-Sub Lee and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Protective Role of TNIP2 in Myocardial Injury Induced by Acute Pancreatitis and Its Mechanism.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Gi-Sang BaeHanbang Body-fluid Research Center, Wonkwang University, Iksan, Jeonbuk, 540-749, South Korea.
Kwang-Ho Heo
Kyoung-Chel Park
Sun Bok Choi
Il-Joo Jo
Seung-Hee Seo
Dong-Goo Kim
Joon-Yeon Shin
Dae-Gil Kang
Ho-Sub Lee
Ho-Joon Song
Byung-Cheul Shin
Sung-Joo Park
Wonkwang University · KRPusan National University · KRPusan National University Yangsan Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimWe have previously reported that bee venom (BV) has a protective role against acute pancreatitis (AP). However, the effects of apamin, the major compound of BV, on AP have not been determined. The aim of this study was to evaluate the effects of apamin on cerulein-induced AP.

methodsAP was induced via intraperitoneal injection of supramaximal concentrations of the stable cholecystokinin analogue cerulein (50 μg/kg) every hour for 6 times. In the apamin treatment group, apamin was administered subcutaneously (10, 50, or 100 μg/kg) at both 18 and 1 h before the first cerulein injection. The mice were sacrificed at 6 h after the final cerulein injection. Blood samples were obtained to determine serum amylase and lipase levels, as well as cytokine production. The pancreas and lung were rapidly removed for morphologic and histological examination, myeloperoxidase (MPO) assay, and real-time reverse transcription-polymerase chain reaction. Furthermore, we isolated the pancreatic acinar cells to specify the role of apamin in AP.

resultsPre-treatment with apamin inhibited histological damage, pancreatic weight/body weight ratio, serum level of amylase and lipase, MPO activity, and cytokine production. In addition, apamin treatment significantly inhibited cerulein-induced pancreatic acinar cell death. Furthermore, apamin treatment inhibited the cerulein-induced activation of c-Jun NH2-terminal kinases (JNK).

conclusionsThese results could suggest that apamin could protect against AP by inhibition of JNK activation.

Indexed as

Acute DiseaseAnimalsApaminCeruletideCholecystokininCytokinesDisease Models, AnimalInjections, IntraperitonealInjections, SubcutaneousMAP Kinase Signaling SystemMiceMice, Inbred C57BLMitogen-Activated Protein Kinase KinasesNF-kappa BPancreasPancreatitisApaminCeruletideCholecystokininCytokinesMitogen-Activated Protein Kinase KinasesNF-kappa B

Identifiers

PMID23918150
OpenAlexW2138897992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.